Quest Diagnostics
DGX
$135.56
Share price
1.13%
Change (1 day)
-2.23%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) - Total assets
Total assets on the balance sheet as of March 2023 : $12.79 B
According to Quest Diagnostics 's latest financial reports the company's total assets are $12.79 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Quest Diagnostics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $12.83 B | -5.69% |
| 2021-12-31 | $13.61 B | -2.96% |
| 2020-12-31 | $14.02 B | 9.21% |
| 2019-12-31 | $12.84 B | 16.72% |
| 2018-12-31 | $11.00 B | 4.76% |
| 2017-12-31 | $10.50 B | 3.99% |
| 2016-12-31 | $10.10 B | 1.39% |
| 2015-12-31 | $9.96 B | 0.86% |
| 2014-12-31 | $9.87 B | 10.38% |
| 2013-12-31 | $8.94 B | -3.62% |
| 2012-12-31 | $9.28 B | -0.32% |
| 2011-12-31 | $9.31 B | 9.21% |
| 2010-12-31 | $8.52 B | -0.42% |
| 2009-12-31 | $8.56 B | 1.9% |
| 2008-12-31 | $8.40 B | -1.89% |
| 2007-12-31 | $8.56 B | 51.3% |
| 2006-12-31 | $5.66 B | 6.7% |
| 2005-12-31 | $5.30 B | 26.22% |
| 2004-12-31 | $4.20 B | -2.27% |
| 2003-12-31 | $4.30 B | 29.4% |
| 2002-12-31 | $3.32 B | 13.43% |
| 2001-12-31 | $2.93 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $20.20 B | 57.89% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Psychemedics PMD | $18.73 M | -99.85% | 🇺🇸 USA |
 NeoGenomics
NEO | $1.74 B | -86.40% | 🇺🇸 USA |
 Qiagen QGEN | $6.28 B | -50.85% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $76.45 M | -99.40% | 🇺🇸 USA |